TrialScientific reports2016

CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients.

Chuang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.